Cannabidiol (CBD)

Key Findings:  Current clinical studies are investigating the use of CBD in mood disorders such as anxiety, control for chronic pain, anti-inflammatory diseases, neurodegenerative diseases such as Alzheimer and Parkinson disease, and antitumorigenic properties. However, none of these trials have yet resulted in FDA approval of CBD oil to treat

Type of Study:  Meta-analysis

Study Result:  Positive

Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable

Receptors Studied:  CB1, CB2, PPAR - Gamma

Study Location(s):  Italy

Year of Pub:  2020

Link to study